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Materials and Methods 
Yeast strains and yeast genetic methods. The S. cerevisiae strains used in this study are 
listed in Supplementary Table 3; all strains, unless otherwise specified, are derivatives of 
W303 (32). Deletion disruption and C-terminal tagging were performed as previously 
described (33, 34). Preparation of media, yeast transformation, and genetic manipulations 
were according to established procedures. 
Plasmid constructs. All recombinant DNA techniques were performed according to 
established procedures using Escherichia coli DH5D for cloning and plasmid propagation. 
All cloned DNA fragments generated by PCR amplification were verified by sequencing. 
Plasmids used in this study are listed in Supplementary Table 4 and Supplementary Table 5. 
Isolation of rpl5 alleles that are synthetically lethal with syo1¨. Random PCR mutagenesis 
of RPL5 was performed as previously described (35) and a library of mutant rpl5mt alleles 
was generated by cloning the rpl5mt PCR fragments into YCplac111-RPL5 (LEU2). Mutant 
rpl5 alleles that are synthetically lethal with the syo1¨ null mutant were isolated by a dual 
screening strategy. Briefly, the rpl5mt-library was transformed into a rpl5¨/syo1¨ double null 
mutant strain (relevant genotype: rpl5::HIS3MX4, syo1::natNT2, ade2, ade3::kanMX4) 
containing the plasmids pHT4467¨-RPL5 (ADE3, URA3) and pHT4467¨(TRP1/¨URA3)-
SYO1 (ADE3, TRP1). Transformants were selected on synthetic dextrose complete (SC)-Leu-
Trp plates and colonies were replica plated onto SC+5-FOA-Leu-Trp plates. Growing 
colonies, bearing viable rpl5 alleles, were restreaked on SC-Leu plates to identify red, non-
sectoring colonies whose growth is dependent on the presence of the SYO1 plasmid. 
Yeast two-hybrid (Y2H) interaction analysis. For Y2H-interaction assays, plasmids 
expressing bait proteins, fused to the Gal4 DNA-binding domain (G4BD), and prey proteins, 
fused to the Gal4 activation domain (G4AD), were co-transformed into reporter strain PJ69-
4A (36). Y2H interactions were documented by spotting representative transformants in 10-
fold serial dilution steps onto SC-Trp-Leu, SC-Trp-Leu-His (HIS3 reporter), and SC-Trp-
Leu-Ade (ADE2) plates, which were incubated for 3-4 d at 30ºC. Growth on SC-Trp-Leu-His 
plates is indicative of a weak/moderate interaction, whereas only relatively strong 
interactions permit growth on SC-Trp-Leu-Ade plates. As a positive control, the combination 
of plasmids pVA3-1 and pTD1-1 (Clontech) was used; these plasmids also served as negative 
control when combined with plasmids expressing bait and prey proteins under investigation. 
Protein expression, purification, and crystallization. Native and seleno-methionine (Se-
Met) labelled ctSyo1ǻN23 were expressed in E. coli BL21(DE3) (Novagen). ctSyo1ǻN23 
and ctRpl5(1-41) were co-expressed in E. coli BL21(DE3) Rosetta 2. For preparation of 
native proteins, cells were grown in lysogeny broth medium (LB) at 37ºC under vigorous 
shaking. Cells expressing ctSyo1ǻN23 in Se-Met labelling conditions were grown in M9 
medium supplemented with 125 mg lysine, 125 mg threonine, 125 mg phenylalanine, 50 mg 
valine, 50 mg leucine, 50 mg isoleucine, 5 g glucose, 250 mM MgCl2, 1 mM CaCl2 and 50 
mg Seleno-L-methionine per litre. Protein expression was induced at an OD600 of 
approximately 0.6 by the addition of IPTG to 1 mM IPTG. After 3 to 6 h of growth, cells 
were harvested and stored at -80°C. Cell pellets were resuspended in 10 ml lysis buffer per 
gram of cells and passed through an M-110L Microfluidizer (Microfluidics). The lysis buffer 
contained 20 mM HEPES pH 8.0, 350 mM NaCl, 10 mM MgCl2, 10 mM KCl. The lysate 
was clarified by centrifugation (125’000 g for 30 min at 4ºC) using a Ti-45 rotor (Beckmann) 
and applied onto a 1 ml HisTrap HP column (GE Healthcare). The column was washed with 
five column volumes of lysis buffer containing 40 mM imidazole and proteins were eluted in 
lysis buffer containing 500 mM imidazole. Subsequently, proteins were concentrated and 
subjected to size-exclusion chromatography using a S200/26–60 column (GE Healthcare) in a 
buffer containing 20 mM HEPES-Na (pH 7.5), 150 mM NaCl, 10 mM KCl, 10 mM MgCl2. 
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Crystallization screens were performed at 291 K by the sitting-drop vapour-diffusion method 
upon mixing equal volumes (0.5 ȝl) of protein solution (30 mg/ml) and crystallization buffer 
with a reservoir volume of 100 ȝl. Crystals of ctSyo1 and Se-Met labelled ctSyo1ǻN23 
appeared within 2-7 d in 0.2 M potassium acetate, 20% (v/v) PEG 3350. Crystals of the 
ctSyo1ǻN23/ctRpl5(1-41) complex appeared within 3-10 d in 0.1 M succinic acid pH 7.0, 
20% (v/v) PEG 3350. 
Data collection and structure determination. Prior to X-ray analysis, crystals were flash-
frozen in liquid nitrogen after cryo-protection by transfer into cryo-solution containing 
mother liquor and 20% (v/v) glycerol. Diffraction data were measured on the tuneable 
beamline ID23-1 under cryogenic conditions (100 K; Oxford Cryosystems Cryostream) at the 
European Synchrotron Radiation Facility (ESRF) in Grenoble, France. X-ray diffraction data 
were processed using iMosflm (37). The initial model of ctSyo1 was obtained from a SAD 
Se-Met dataset of ctSyo1ǻN23 using the AutoSol and Autobuild programs of the Phenix 
program suite (38). The structures of ctSyo1 and the ctSyo1ǻN23/ctRpl5(1-41) complex 
were obtained by molecular replacement using Phaser (37) and the structure of ctSyo1ǻN23 
as search model. Model building and refinement was performed with the Phenix program 
suite (38) and COOT (39). Figures were prepared in PyMOL (http://pymol.org/). 
Preparation of 5S rRNA. The DNA encoding 5S rRNA was amplified from genomic DNA 
of C. thermophilum. The sequence of the 5S rDNA from C. thermophilum is: 5’-
ACGTACGACCATACCCAGTGGAAAGCACGGCATCCCGTCCGCTCTGCCCTAGTTA
AGCCACTGAGGGCCCGGTTAGTAGTTGGGTCGGTGACGACCAGCGAATCCCGGG
TGTTGTACGTT-3’. The fragment was cloned into pUC18 via the KpnI and BamHI 
restriction sites. The forward primer additionally contained a T7 promoter sequence. The 
RNA was produced by in vitro transcription as described in (40, 41). Prior to the biochemical 
assays, purified 5S rRNA was heated to 75ºC for 10 min and snap-cooled on ice to ensure 
proper folding. 
FG-repeat binding assays. In vitro binding assays with immobilized GST-tagged FG-
repeats of nucleoporins were performed as described (27). BIAcore binding assays and 
determination of dissociation constants was done as described (27). 
In vitro import assays. In vitro import assays with permeabilized HeLa cells were performed 
as previously described (26, 27). To monitor nuclear translocation by fluorescence 
microscopy (Axiophot 2 or Axiovert 100M microscope, Zeiss), purified proteins were either 
fluorescently labelled with Alexa-488 or, when tagged with the Flag epitope, detected with 
rabbit anti-FLAG (Sigma) and Alexa-488 labelled secondary donkey anti-rabbit (Invitrogen) 
antibodies. Nuclei were revealed by staining DNA with Hoechst. 
Determination of the absolute MW by SLS/RI measurements. The apparent molecular 
weight was analyzed by size-exclusion chromatography using a S200/26–60 column (GE 
Healthcare). The buffer was 20 mM Hepes 7.5, 150 mM NaCl, 10 mM MgCl2, and 10 mM 
KCl. The absolute molecular weight was determined by static light scattering (mini Dawn 
Tristar; Wyatt Technologies) and refractive index analysis (WGE Dr. Bures ǻn1000, 
Dallgow, Germany). 
Amide HDX-MS Experiments. Amide HDX-MS experiments were performed as described 
(42, 43). Amide HDX was initiated by a 20-fold dilution of either 200 pmol ctSyo1 or 
ctSyo1-ctRpl11 complex into D2O buffer containing 20 mM Hepes (pH 7.5), 150 mM NaCl, 
10 mM MgCl2, and 10 mM KCl at 30ºC. After 10 sec the exchange reaction was quenched by 
decreasing the temperature to 0ºC and the pH with ice-cold quench buffer (400 mM 
KH2PO4/H3PO4, pH 2.2). Quenched samples were digested with pepsin and then injected into 
an HPLC-MS setup as described. The deuteron content of the peptic peptides covering the 
ctSyo1 or ctSyo1-ctRpl11 complex were determined from the centroid of the molecular ion 
isotope envelope. The deuteron content was calculated after adjustment for deuteron gain/loss 
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during digestion and HPLC-MS setup. For this adjustment, nondeuterated and fully 
deuterated ctSyo1 were analyzed (44). Fully deuterated samples were prepared by 3 cycles of 
drying and resolubilization in D2O containing 6 M guanidium hydrochloride. The 0% control 
was not treated with D2O. 
Miscellaneous. Polysome profiles were analysed by sucrose gradient centrifugation as 
previously described (45, 46). Tandem-affinity purifications were, unless otherwise indicated, 
performed in a buffer containing 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 5 mM MgCl2, 5% 
glycerol, and 0.1% NP-40 as previously described (46). Elution from Calmodulin-Sepharose 
beads (GE Healthcare) was performed in the presence of 5 mM EGTA and elution from anti-
FLAG M2 affinity gel (Sigma) was carried out by incubation with 0.1 mg/ml FLAG peptide. 
Standard methods were used to purify (His)6- or GST-tagged proteins from E. coli. 
Recombinant proteins were revealed by Western analysis with mouse monoclonal anti-FLAG 
M2 (Sigma) or anti-penta-His (Qiagen) antibodies and secondary goat anti-mouse 
horseradish peroxidase conjugated antibodies (Bio-Rad). Live yeast cells were imaged by 
fluorescence microscopy using either a Zeiss Imager Z1 or an Olympus BX54 microscope. 
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Fig. S1. Syo1 binds to the N-terminal extension of Rpl5. (A, B) The N-terminal extension of 
Rpl5 is required and sufficient for the interaction with Syo1. (A) Mapping of the Syo1 
binding site on Rpl5 by Y2H-interaction assay. The Rpl5(1-250) construct lacks the C-
terminal extension of Rpl5. The Rpl5¨N25 construct lacks the first 25 amino acids of Rpl5 
and begins with glycine 26. (B) In vitro binding assay between Syo1 and Rpl5. Syo1-Flag 
and the indicated C-terminally (His)6-tagged Rpl5 variants were co-expressed from pETDuet-
1 (Novagen). Proteins, purified via Nickel-ion affinity chromatography, were eluted with 250 
mM imidazole and revealed by SDS-PAGE and Coomassie staining (upper panels) or by 
Western analysis using anti-FLAG (Syo1-Flag) and anti-penta-His (Rpl5-(His)6 variants) 
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antibodies (lower panels). The buffer used for the purification had the following composition: 
50 mM Tris-HCl pH 7.5, 200 mM NaCl, 1.5 mM MgCl2, 5% glycerol, and 0.1% NP-40. T, 
total extract; P, pellet fraction (insoluble proteins); S, soluble extract; E, eluate; M, molecular 
weight standard. The bands marked by a blue arrowhead correspond to the different Rpl5 
variants used as baits for the purifications. Black arrowheads indicate the position of Syo1-
Flag. (C, D) The N-terminal extension of ctRpl5 is sufficient for the interaction with ctSyo1. 
(C) Y2H-interaction assay between ctSyo1 and ctRpl5 or ctRpl5(1-41). (D) In vitro binding 
assay between ctSyo1 and ctRpl5 or ctRpl5(1-41). Black and blue arrowheads indicate 
ctSyo1 and ctRpl5-(His)6 or ctRpl5(1-41)-(His)6, respectively. M, molecular weight standard. 
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Fig. S2. Syo1 and Rpl5 functionally interact. (A) Increased dosage of Rpl5 suppresses the 
syo1¨ null mutant phenotype. The syo1¨ null mutant was transformed with YCplac111, 
YCplac111-SYO1, YCplac111-RPL5, and YEplac181-RPL5. Transformants were restreaked 
and cells were spotted in 10-fold serial dilution steps onto SC-Leu plates, which were 
incubated at 23ºC for 3 d or at 16ºC for 7 d. CEN, centromeric plasmid; 2, multicopy 
plasmid. (B) The syo1¨ null mutant is synthetically lethal with distinct rpl5 alleles. 
YCplac111, YCplac111-RPL5, YCplac111-rpl5.V53G, and YCplac111-rpl5.G169S were 
transformed into a RPL5 shuffle strain (rpl5::HIS3MX4 ade3::kanMX4 pHT4467¨-RPL5) 
and a RPL5/syo1¨ shuffle strain (rpl5::HIS3MX4 syo1::natNT2 ade3::kanMX4 pHT4467¨-
RPL5). Transformants were restreaked and cells were spotted in 10-fold serial dilution steps 
onto SC-Leu and SC+5-fluoroorotic acid (5-FOA) plates, which were incubated at 30ºC for 4 
d. The rpl5.V53G allele has originally also been described as rpl5-HA-3 (47). Note that the 
other published, viable rpl5 alleles (HA-1, HA-2, HA-4, HA-5, and HA-9) are not 
synthetically lethal with the syo1¨ null mutant (data not shown). (C) Overexpression of Syo1 
rescues the slow-growth phenotypes of rpl5 alleles. YCplac22, YCplac22-RPL5, YCplac22-
SYO1, and YEplac112-SYO1 were co-transformed with YCplac111-rpl5.V53G, YCplac111-
rpl5.G169S or YCplac111-rpl5.L104S into a RPL5 shuffle strain. Transformants were 
restreaked and cells were spotted in 10-fold serial dilution steps onto SC-Leu-Trp and SC+5-
FOA plates, which were incubated at 30ºC for 3 d or 4 d. 
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Fig. S3. Interaction of L5-N with ctSyo1. (A) Residues of L5-N involved in binding to 
ctSyo1, of which the electrostatic surface is shown. L5-N binds into an elongated, 
hydrophobic groove, which is lined by electrostatic residues. (B) Residues of ctSyo1 
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involved into L5-N binding. The Figure was created with Ligplot. Note: Arg15 of L5-N 
might be further involved in two potential salt bridges with Asp550 and Glu651 of ctSyo1.  
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Fig. S4. Conformational rearrangements of ctSyo1 upon L5-N binding. The crystal structures 
of ctSyo1 (green) and ctSyo1 (blue) bound to L5-N (red) were superimposed on their ARM 
domains (rmsd = 2,2 Å). The comparison shows that the HEAT domain of ctSyo1 is 
translated for approximately 10 Å relatively to the ARM domain. 
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Fig. S5. Comparison of the ligand-binding mode between importin-D and ctSyo1. (A) 
Superposition of two structures of importin-D (grey)in complex with Nup2 (red, PDB: 2C1T 
(24) or PDB: 3TJ3). (B) Equivalent view of the structure of ctSyo1 (grey) in complex with 
L5-N (green) (this study). 
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Fig. S6. Analysis of ctSyo1/Rpl11 interaction: Part of the ctSyo1 acidic loop contributes to 
ctRpl11 binding. (A) Mapping of the ctRpl11 binding sites on ctSyo1 by HDX-MS analysis.
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Deuteron incorporation into uncomplexed Syo1 (left panel) and ctSyo1 bound to ctRpl11 
(middle panel) after 10 sec of incubation in D2O. Results are shown as fraction exchanged in 
% of total exchangeable amides in the particular peptide. The numbers corresponding to the 
protein segments (peptides) are indicated on the left. Difference plot of the number of 
deuterons incorporated into the ctSyo1-ctRpl11 complex compared to free ctSyo1 (right 
panel). In the difference plot, bars to the left indicate ctRpl11-induced protection in Syo1  
(less deuteron incorporation). (B) Sequence of the ctSyo1 disordered loop and secondary 
structure prediction with Psipred (48). The black and red bars indicate the positions of the 
generated 5 amino acid deletions in ctSyo1 and the major binding site of ctRpl11 on ctSyo1 
as identified by HX-MS, respectively. (C) In vitro binding assay between ctSyo1 and its 
variants and ctRpl11. Proteins were co-expressed in E. coli, purified via Nickel-ion affinity 
purification and revealed by SDS-PAGE and Coomassie staining. 
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Fig. S7. The ARM-repeat domain of Syo1 contributes to Rpl11 binding. Mapping of the Rpl5 
and Rpl11 binding sites on Syo1 by Y2H-interaction assay. Progressive N-terminal deletion 
constructs of Syo1 were tested for their interaction with full-length Rpl5 and Rpl11, 
respectively. 
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Fig. S8. Possible domain organisation of the Syo1-Rpl5-Rpl11 complex. The basis for this 
illustration is the crystal structure of ctSyo1 (salmon) in complex with L5-N. The globular 
domain of Rpl5 (green) was taken from the crystal structure of the 80S ribosome from S. 
cerevisiae (13) and arbitrarily placed following the L5-N peptide (see ‘green dashed line’). 
Rpl11 (blue) was placed in close proximity to the disordered loop of Syo1 (black dashed 
lines), which provides a key interaction site (see fig. S6). As a consequence, Rpl11 would 
likely contact the ARM domain of Syo1, which is also involved in the Syo1/Rpl11 interaction 
(see fig. S7). Note: The intention of the figure is to provide an idea about the relative protein 
sizes and a possible domain arrangement. It is not meant as a precise molecular model of the 
Syo1-Rpl5-Rpl11 complex. With this intention, the authors also included the structure of the 
5S rRNA as observed in the 80S ribosome (13). The arrow indicates the direction how the 5S 
rRNA could ‘meet’ the Syo1-Rpl5-Rpl11 complex to form the stable complex described in 
Fig. 4. 
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Fig. S9. Syo1 traverses the NPC by facilitated diffusion. (A, B) Syo1 interacts with FG-
repeats of nucleoporins. (A) Binding of recombinant Syo1 to immobilized FG-repeat 
domains of nucleoporins (GST-Nup) in the presence of competitor E. coli lysate. Lane 1, 
purified Syo1 (p); lane 2, Syo1 mixed with E. coli lysate (input, i); lane 3, molecular weight 
standard (M), same as in Fig. S1B; lanes 4-19, proteins bound to the indicated GST-Nups or 
the GST control in the absence (-) or presence of increasing amounts of Syo1 (1x, 3x, 9x). 
Bound proteins were analyzed by SDS-PAGE and Coomassie staining (upper panel) or 
Western analysis (lower panel) with anti-penta-His antibody (Syo1). (B) BIAcore analysis of 
the interaction between Syo1 and the FG-repeat domain of Nup100. GST-Nup100 was 
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immobilized and different concentrations (0.91 - 7.28 M) of purified Syo1 were injected 
over the sensor chip. The dissociation constant (Kd) for Syo1 binding to FG-repeats of 
Nup100 was determined by Scatchard analysis. Sensor responses at equilibrium (Req) were 
derived for each protein concentration from the sensorgram, and Req/concentration of Syo1 
values were plotted as a function of Req. (C, D) In vitro nuclear import assays. HeLa cells 
were permeabilized by digitonin and incubated with purified, Alexa488-labelled Syo1 or 
GST-SV40NLS-mRFP in transport buffer (C, upper panel), transport buffer containing either 
cytosol/energy (C, middle panel) or cytosol/energy/WGA (C, lower panel) at 37ºC. 
Permeabilized HeLa cells were pre-treated with transport buffer containing cytosol/energy in 
the absence or presence of WGA before performing the import reactions. (D) In vitro import 
assay with purified, Alexa488-labelled Syo1 at 4ºC in the absence or presence of WGA (left 
panel) and with purified Syo1-2xyEGFP at 30ºC in the absence or presence of WGA (right 
panel). (E) Syo1 can re-equilibrate across the NPC after nuclear accumulation. Permeabilized 
HeLa cells were incubated with purified, Alexa488-labelled Syo1 in transport buffer, then 
cells were washed with buffer (t = 0) and the Syo1 signal was monitored over time (t = 5, 15, 
30, and 60 min). At longer time points, the nucleoplasmic signal of labelled Syo1 is clearly 
reduced, while a fraction of Syo1 remains associated with sub-nuclear regions that likely 
correspond to nucleoli. 
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Fig. S10. In vitro nuclear import assays and BIAcore FG-binding assays with ctSyo1, 
ctSyo1-ctRpl5, ctSyo1-ctRpl11 and ctSyo1-ctRpl5-ctRpl11. (A) Protein input for import and 
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BIAcore assays. ctSyo1-Flag-(His)6 (lane 1), ctSyo1-Flag/ctRpl5/ctRpl11-(His)6 (lane 2), 
ctSyo1-Flag/ctRpl5-(His)6 (lane 3), and ctSyo1-Flag/ctRpl11-(His)6 (lane 4) were purified via 
Nickel-ion affinity chromatography and analyzed by SDS-PAGE and Coomassie staining. 
Black, blue, and red arrowheads indicate ctSyo1-Flag/ctSyo1-Flag-(His)6, ctRpl5/ctRpl5-
(His)6, and ctRpl11-(His)6, respectively. M, molecular weight standard. (B) In vitro nuclear 
import assays. HeLa cells were permeabilized by digitonin and incubated with purified 
ctSyo1 or the ctSyo1-ctRpl5, ctSyo1-ctRpl11, and ctSyo1-ctRpl5-ctRpl11 complexes in 
transport buffer (upper panel) or transport buffer containing cytosol and energy (GTP/ATP) 
(lower panel) for 30 min at 30ºC. Nuclear translocation of ctSyo1 or the ctSyo1-containing 
complexes was revealed by indirect immunofluorescence against Flag-tagged ctSyo1. (C) 
BIAcore analysis of the interaction between purified ctSyo1 or the ctSyo1-ctRpl5, ctSyo1-
ctRpl11, and ctSyo1-ctRpl5-ctRpl11 complexes and the FG-repeat domain of Nup100. GST-
Nup100 was immobilized and different concentrations (0.045 - 0.48 M) of purified ctSyo1 
or the ctSyo1-containing complexes were injected over the sensor chip. 
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Fig. S11. The PY-NLS of Syo1 is sufficient to mediate interaction with Kap104 and nuclear 
targeting of a GFP reporter. (A) Identification of Kap104 as a Syo1 interacting protein by
tandem-affinity purification of C-terminally FTpA-tagged Syo1 from yeast cell lysates. Cells 
were grown in YPD at 30ºC to an OD600 of around 4 and cells were lysed in a buffer 
containing 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 1.5 mM MgCl2, 5% glycerol, and 0.1% 
NP-40. The final eluate was analyzed by SDS-PAGE and Coomassie staining. Proteins 
indicated by arrowheads were identified by mass spectrometry. M, molecular weight 
standard. Note that the observed differences compared to the purification shown in Fig. 1B 
are likely due to the different growth (YPD 23ºC, OD600 of around 1.2) and purification 
(same buffer, but 5 mM MgCl2) conditions. (B) Syo1 contains a basic PY-NLS at its N-
terminus. bPY-NLS, consensus PY-NLS; S.c., S. cerevisiae; A.g., Ashbya gossypii; K.l., 
Kluyveromyces lactis; Y.l.; Yarrowia lipolytica; S.j., Schizosaccharomyces japonicus; S.p., 
Schizosaccharomyces pombe; N.c., Neurospora crassa; C.g., Chaetomium globosum; C.t., 
Chaetomium thermophilum. (C) The PY-NLS of Syo1 interacts with Kap104. In vitro 
binding assay between purified Kap104-(His)6 (input, lane 1) and immobilized GST fusion 
proteins [lane 2, (GA)5-TEV-GST; lane 3, bPY(Nab2)-(GA)5-TEV-GST; lane 4, Syo1(1-21)-
(GA)5-TEV-GST]. bPY(Nab2), amino acids 216-242 of Nab2. Bound proteins, eluted from 
GSH-Sepharose by boiling in sample buffer, were revealed by SDS-PAGE and Coomassie 
staining (upper panel) or by Western analysis using anti-penta-His antibody (lower panel). M, 
molecular weight standard. The buffer used for the binding assay had the following 
composition: 20 mM HEPES pH 7.5, 110 mM K-acetate, 2 mM Mg-acetate, 2 mM EGTA, 
20% glycerol, and 1 mM DTT. (D) The PY-NLS of Syo1 targets a 3xyEGFP reporter to the 
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nucleus. bPY(Nab2), amino acids 216-242 of Nab2. Nuclei were revealed by the nucleolar 
marker protein Nop58-RedStar2. 
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Fig. S12. The PY-NLS of Syo1 is required for nuclear targeting and interaction with Kap104. 
(A) The PY-NLS is required for in vitro binding of ctSyo1 to ctKap104. In vitro binding 
assay between GST-ctKap104 (lane 1) and ctSyo1 (lane 2; input lane 4) or ctSyo1¨N23 (lane 
3; input lane 5). Bound proteins were revealed by SDS-PAGE and Coomassie staining. M, 
molecular weight standard. (B) The PY-NLS is essential for Syo1 in vivo function. The 
syo1¨ null mutant was transformed with YCplac111, YCplac111-SYO1, YCplac111-
syo1¨N9, YCplac111-syo1¨N21, and YCplac111-bPY(NAB2)-syo1¨N21. Transformants 
were restreaked and cells were spotted in 10-fold serial dilution steps onto SC-Leu plates, 
which were incubated at 23ºC for 3 d or at 16ºC for 7 d. syo1¨N9, Syo1 variant lacking the 
first 9 residues; syo1¨N21, Syo1 variant lacking the first 21 residues; bPY(NAB2)-
syo1¨N21, codes for amino acids 216-242 of Nab2 fused to a Syo1 variant lacking the first 
21 residues. (C) The PY-NLS is required for nuclear targeting of Syo1. Syo1-GFP, 
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Syo1¨N9-GFP, Syo1¨N21-GFP, and bPY(Nab2)-Syo1¨N21-GFP were expressed from 
plasmid under the control of the cognate SYO1 promoter in syo1¨ cells and the localization 
was assessed by fluorescence microscopy. (D) Kap104 is required for nuclear accumulation 
of Syo1. Localization of chromosomally expressed Syo1-GFP in wild-type (KAP104) or 
temperature-sensitive kap104-16 mutant (kap104-16) cells shifted for 20 min to the non-
permissive temperature. DIC, differential interference contrast. (E) Syo1-Rpl5-Rpl11 form a 
trimeric complex that is recruited via the PY-NLS of Syo1 to Kap104. In vitro binding assay 
between GST-Kap104-(His)6, immobilized on GSH-Sepharose, and Syo1-Flag/Rpl5-
(His)6/Rpl11 or Syo1¨N21-Flag/Rpl5-(His)6/Rpl11. Trimeric Syo1-Flag/Rpl5-(His)6/Rpl11 
(lane 1) or Syo1¨N21-Flag/Rpl5-(His)6/Rpl11 (lane 2) complexes were obtained by lysing 
cells having co-expressed Syo1-Flag/Rpl5-(His)6 or Syo1¨N21-Flag/Rpl5-(His)6 together 
with cells having expressed Rpl11 followed by Nickel-ion affinity chromatography. 
Immobilized GST-Kap104-(His)6 was incubated with buffer (lane3), Syo1-Flag/Rpl5-
(His)6/Rpl11 (lane 4) or Syo1¨N21-Flag/Rpl5-(His)6/Rpl11 (lane 5). For control purposes, 
immobilized GST was incubated with Syo1-Flag/Rpl5-(His)6/Rpl11 (lane 6) or Syo1¨N21-
Flag/Rpl5-(His)6/Rpl11 (lane 7). Bound proteins, eluted from GSH-Sepharose by boiling in 
sample buffer, were analyzed by SDS-PAGE and Coomassie staining. The identity of the 
indicated proteins (1-4) was verified by mass spectrometry. M, molecular weight standard. 
The buffer used for the binding assay had the following composition: 20 mM HEPES pH 8, 
150 mM NaCl, 10 mM MgCl2, 10 mM KCl, 1 mM DTT, and 0.1% NP-40. 
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Table S1. Determination of absolute molecular weights of Syo1 and Syo1-containing complexes. 
 
 
The absolute molecular weights (MW) were determined from static light scattering (SLS) and 
refractive index measurements (RI). The MW is given in kDa. 
 Calculated MW Absolute MW 
ctSyo1-(His)6 75.6 73.7 ± 0.6 % 
(His)6-ctKap104 106.3 106.8 ± 0.4 % 
ctSyo1-Flag / ctRpl5 / ctRpl11-(His)6  
132.8 
 
131.1 ± 0.8 % 
ctSyo1-Flag / ctRpl5 / ctRpl11-(His)6 
/ (His)6-ctKap104 
 
239.0 
 
240.0 ± 1.2 % 
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Table S2. Data collection, phasing and refinement statistics.

ctSyo1'N23 
Se-Met 
ctSyo1/ 
ctRpl5-N 
ctSyo1
Data collection     
Space group  P 1 21 1 C 2 2 21 C2 
Cell dimensions ҏҏ     
    a, b, c (Å)  49.05, 
81.27, 
83.37 
79.6  
104.2  
182.3 
166.4
59.7 
69.6 
ҏҏҏҏDEJҏ (q)  90.00, 
94.97, 
90.00 
90.00, 90.00, 
90.00 
90
97.7 
90
 Peak 
Energy (keV)  12.6616   
Resolution (Å)  58.09-2.43 63.3-2.95  
(3.11 – 2.95)
41.2 – 2.1 
(2.21 – 2.1)
Rmerge  0.087 (0.45) * 0.127 (0.44) 0.078 (0.47) 
I / VI  21.8 (5.8) 11.2 (4.4) 9.5 (2.6) 
Completeness (%)  99.9 (99.3) 100 (100) 99.8 (99.5) 
Redundancy  14.5 (14.0) 7.1 (7.2) 3.8 (3.7)
Anomalous  
completeness 
Anomalous  
Redundancy 
99.8 (98.8) 
7.3 (7.1) 
Refinement     
Resolution (Å)  48.8 – 2.4 45.2 – 2.95 40.5 – 2.1 
No. reflections  24492 15983 39659
Rwork / Rfree  21.7/27.1 20.3/25.9 21.9/25.5 
No. atoms     
    Protein  4154 4412 4548 
    Ligand/ion  0 0 0 
    Water  100 0 218 
R.m.s deviations     
    Bond lengths (Å)  0.017 0.009 0.008 
    Bond angles (q)  1.657 1.338 1.105 
Ramachandran (%)     
Preferred   94.3 96 
Allowed   5.3 3.45 
Outliers   0.36 0.55 
*Values in parentheses are for highest-resolution shell.
The following amino acid residues could not be resolved due to lacking electron density: 
ctSyo1: 1 - 24; 326 - 407; 538 - 550 
ctSyo1-ctRpl5-N: 1 - 33; 328 - 406; 538 - 550 

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Table S3. Yeast strains used in this study. 
Name  Relevant genotype Source 
    
Y3833 MATD wild type This study 
Y3834 MATD syo1::natNT2 This study 
Y3840* MATD NOP58-RedStar2::natNT2 This study 
Y3877# MATa rpl5::kanMX6  pRS315-RPL5-TAP 
his3 leu2 lys2 ura3 TRP1 MET15 
This study 
Y4047 MATa SYO1-FTpA::HIS3MX4 This study 
Y4051 MATa syo1::natNT2 ade3::kanMX4 This study 
Y4248 MATa kap104::natNT2 SYO1-GFP::HIS3MX4 ade3::kanMX4 
pRS316-KAP104 
This study 
Y4462 MATa rpl5::HIS3MX4 syo1::natNT2 ade3::kanMX4 
pHT4467¨-RPL5 
This study 
Y4465 MATD rpl5::HIS3MX4 ade3::kanMX4 pHT4467¨-RPL5 This study 
PJ69-4A# MATa trp1-901 leu2-3,112 ura3-52 his3-200 gal4¨ gal80¨ 
LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ 
James et al. (36) 
    
 
Strains used in this study were derived from W303 (MATa/MATD ade2-1/ade2-1 his3-11,15/his3-11,15 leu2-
3,112/leu2-3,112 trp1-1/trp1-1 ura3-1/ura3-1 can1-100/can1-100) (32). Strains derived from DS1-2b (MATD 
his3-¨200 leu2-¨1 trp1-¨63 ura3-52) (49) are marked by an asterisk; # indicates strains of other genetic 
backgrounds. 
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Table S4. S. cerevisiae plasmids used in this study*. 
Name Relevant information Source 
YCplac111-SYO1 CEN, LEU2, PSYO1, TSYO1 This study 
YCplac22-SYO1 CEN, TRP1, PSYO1, TSYO1 This study 
YEplac112-SYO1 2, TRP1, PSYO1, TADH1 This study 
YCplac111-SYO1-(GA)5-
yEGFP 
CEN, LEU2, PSYO1, TSYO1, C-terminal yEGFP  This study 
pADH111-(GA)5-3xyEGFP CEN, LEU2, PADH1, TADH1, C-terminal 3xyEGFP This study 
pADH111-SYO1(1-21)-
(GA)5-3xyEGFP 
CEN, LEU2, PADH1, TADH1, C-terminal 3xyEGFP This study 
pADH111-bPY(NAB2)-
(GA)5-3xyEGFP 
CEN, LEU2, PADH1, TADH1, C-terminal 3xyEGFP This study 
pHT4467¨(TRP1/¨URA3)-
SYO1 
CEN6 (instable), TRP1, ADE3 This study 
pHT4467¨-RPL5 CEN6 (instable), URA3, ADE3 Hurt lab plasmid 
YCplac111-RPL5 CEN, LEU2, PRPL5, TRPL5 This study 
YEplac181-RPL5 2, LEU2, PRPL5, TRPL5 This study 
YCplac22-RPL5 CEN, TRP1, PRPL5, TRPL5 This study 
pRS315-RPL5-TAP CEN, LEU2, PRPL5, TGAL4, C-terminal TAP tag Hurt lab plasmid 
pRS316-KAP104 CEN, URA3, PKAP104, TKAP104 Aitchison et al. (31) 
pRS314-kap104-16 CEN, TRP1, PKAP104, TKAP104 Aitchison et al. (31) 
pVA3-1 amino acids 72-390 of murine p53 expressed from 
pAS1CYH2; 2, TRP1, PADH1, N-terminal G4BD 
Clontech 
pTD1-1 amino acids 87-708 of SV40 large T-antigen expressed 
from pACT2; 2, LEU2, PADH1, N-terminal G4AD 
Clontech 
pG4BDC22-SYO1 CEN, TRP1, PADH1, TADH1, C-terminal G4BD This study 
pG4BDC22-ctSYO1 CEN, TRP1, PADH1, TADH1, C-terminal G4BD This study 
pG4BDC(¨myc)22 CEN, TRP1, PADH1, TADH1, C-terminal G4BD(¨myc) This study 
pG4BDC(¨myc)22-SYO1 CEN, TRP1, PADH1, TADH1, C-terminal G4BD(¨myc) This study 
pG4ADC111-RPL5 CEN, LEU2, PADH1, TADH1, C-terminal G4AD This study 
pG4ADC111-ctRPL5 CEN, LEU2, PADH1, TADH1, C-terminal G4AD This study 
pG4ADC181-RPL11B 2, LEU2, PADH1, TADH1, C-terminal G4AD This study 
pGAG4ADC181 2, LEU2, PADH1, TADH1, C-terminal (GA)5-G4AD This study 
pFA6a-HIS3MX4 for genomic deletion disruption Longtine et al. (34) 
pFA6a-natNT2 for genomic deletion disruption Janke et al. (33) 
pFA6a-GFP-HIS3MX4 GFP(S65T), TADH1; for genomic C-terminal tagging Longtine et al. (34) 
pFA6a-FTpA-HIS3MX4 FTpA, TADH1; for genomic C-terminal tagging This study 
pFA6a-RedStar2-natNT2 pYM43; RedStar2; for genomic C-terminal tagging Janke et al. (33) 
 
*For simplicity, only the plasmids containing wild-type SYO1, RPL5, and KAP104 are listed; variants/mutants 
thereof were cloned into the listed plasmids. P and T denote promoter and terminator, respectively. 
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Table S5. E. coli expression plasmids used in this study*. 
Name Relevant information Source 
pET-15b/SYO1-(His)6 ampr, T7 promoter/lac operator This study 
pET-22b/SYO1-2xyEGFP-(His)6 ampr, T7 promoter/lac operator This study 
pETDuet-1/RPL5-(His)6-SYO1 ampr, T7 promoter/lac operator This study 
pETDuet-1/RPL5-(His)6-SYO1-Flag ampr, T7 promoter/lac operator This study 
pET-24d/(GA)5-TEV-GST kanr, T7 promoter/lac operator This study 
pET-24d/SYO1(1-21)-(GA)5-TEV-GST kanr, T7 promoter/lac operator This study 
pET-24d/bPY(NAB2)-(GA)5-TEV-GST kanr, T7 promoter/lac operator This study 
pET-15b/ctSYO1 ampr, T7 promoter/lac operator This study 
pET-15b/ctSYO1-(His)6 ampr, T7 promoter/lac operator This study 
pET-15b/ctSYO1-Flag-(His)6 ampr, T7 promoter/lac operator This study 
pETDuet-1/ctRPL5-(His)6-ctSYO1 ampr, T7 promoter/lac operator This study 
pETDuet-1/ctRPL5-ctSYO1-Flag ampr, T7 promoter/lac operator This study 
pET-24d/RPL11B kanr, T7 promoter/lac operator This study 
pET-24d/ctRPL11 kanr, T7 promoter/lac operator This study 
pET-24d/ctRPL11-(His)6 kanr, T7 promoter/lac operator This study 
pET-15b/KAP104-(His)6 ampr, T7 promoter/lac operator This study 
pET-24d/GST-TEV-(GA)5 kanr, T7 promoter/lac operator This study 
pET-24d/GST-TEV-(GA)5-KAP104-(His)6 kanr, T7 promoter/lac operator This study 
pET-24d/GST-TEV-(His)6-ctKAP104 kanr, T7 promoter/lac operator This study 
pET-24d/(His)6-ctKAP104 kanr, T7 promoter/lac operator This study 
pProEX/(His)6-TEV-ctGSP1 ampr, trc promoter This study 
pGEX-2TK-NUP100(1-640) ampr, tac promoter Allen et al. (50) 
pGEX-2TK-NUP116(165-715) ampr, tac promoter Allen et al. (50) 
pGEX-2TK-NUP1(332-1076) ampr, tac promoter Allen et al. (50) 
pGEX-2T/NLS-RFP ampr, tac promoter, GST-SV40NLS-mRFP Yoneda lab plasmid 
 
*For simplicity, only the plasmids containing wild-type SYO1 or RPL5 are listed; variants/mutants thereof were 
cloned into the listed plasmids. 

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